1. Home
  2. PICS vs PGEN Comparison

PICS vs PGEN Comparison

Compare PICS & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PICS

PicS N.V. Class A Common Shares

N/A

Current Price

$13.08

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.01

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PICS
PGEN
Founded
2012
1998
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PICS
PGEN
Price
$13.08
$4.01
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$22.00
$8.33
AVG Volume (30 Days)
702.6K
5.4M
Earning Date
05-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$29.68
$1,115.92
Revenue Next Year
$39.06
$81.04
P/E Ratio
$29.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.88
$1.23
52 Week High
$18.49
$5.47

Technical Indicators

Market Signals
Indicator
PICS
PGEN
Relative Strength Index (RSI) 53.44 53.07
Support Level $10.09 $3.31
Resistance Level $15.33 $4.44
Average True Range (ATR) 0.79 0.34
MACD 0.37 0.07
Stochastic Oscillator 89.54 71.43

Price Performance

Historical Comparison
PICS
PGEN

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: